Evidence map›Paper›PMID 31262785›Full record

ArticleJournal of cell science2019

Real-time imaging of integrin β4 dynamics using a reporter cell line generated by Crispr/Cas9 genome editing.

Ameer L Elaimy, Mengdie Wang, Ankur Sheel, Caitlin W Brown, Melanie R Walker, John J Amante, Wen Xue, Amanda Chan, Christina E Baer, Hira Lal Goel and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ameer L ElaimyDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.ORCID 0000-0002-9210-6114
Mengdie WangMedical Scientist Training Program, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.
Ankur SheelMedical Scientist Training Program, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.
Caitlin W BrownDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.
Melanie R WalkerDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.
John J AmanteDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.
Wen XueRNA Therapeutics Institute, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.
Amanda ChanDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.
Christina E BaerDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.
Hira Lal GoelDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA.
Arthur M MercurioDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01605, USA arthur.mercurio@umassmed.edu.ORCID 0000-0003-2762-7519
University of Massachusetts Chan Medical School · US

Funding

VEGF Signaling in Mammary TumorigenesisR01CA168464 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MERCURIO, ARTHUR M · 2012 to 2021
$3.7M
Integrin splicing and cancer stem cell fateR01CA203439 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MERCURIO, ARTHUR M · 2016 to 2020
$1.9M
Mechanisms of Carcinoma Initiation and DifferentiationR50CA221780 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOEL, HIRA · 2018 to 2022
$1.1M
Integrin Function in Breast Cancer InitiationF30CA206271 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ELAIMY, AMEER · 2016 to 2021
$155k
Exploiting RNAi-based silencing of Myc and metabolic vulnerabilities to prevent relapse after Kras inhibition in lung cancerF30CA232657 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SHEEL, ANKUR · 2018 to 2020
$123k
NCI NIH HHS F30 CA206271NCI NIH HHS F30 CA232657NCI NIH HHS R01 CA168464NCI NIH HHS R01 CA203439NCI NIH HHS R50 CA221780
6 · The paper itself

Abstract

The ability to monitor changes in the expression and localization of integrins is essential for understanding their contribution to development, tissue homeostasis and disease. Here, we pioneered the use of Crispr/Cas9 genome editing to tag an allele of the β4 subunit of the α6β4 integrin. A tdTomato tag was inserted with a linker at the C-terminus of integrin β4 in mouse mammary epithelial cells. Cells harboring this tagged allele were similar to wild-type cells with respect to integrin β4 surface expression, association with the α6 subunit, adhesion to laminin and consequent signaling. These integrin β4 reporter cells were transformed with YAP (also known as YAP1), which enabled us to obtain novel insight into integrin β4 dynamics in response to a migratory stimulus (scratch wound) by live-cell video microscopy. An increase in integrin β4 expression in cells proximal to the wound edge was evident, and a population of integrin β4-expressing cells that exhibited unusually rapid migration was identified. These findings could shed insight into integrin β4 dynamics during invasion and metastasis. Moreover, these integrin β4 reporter cells should facilitate studies on the contribution of this integrin to mammary gland biology and cancer.This article has an associated First Person interview with the first author of the paper.

Indexed as

CRISPR-Cas SystemsGene EditingAdaptor Proteins, Signal TransducingHumansIntegrin alpha6Integrin beta4Microscopy, VideoTranscription FactorsYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingIntegrin alpha6Integrin beta4ITGA6 protein, humanITGB4 protein, humanTranscription FactorsYAP1 protein, humanYAP-Signaling ProteinsCrispr/Cas9Integrin β4MigrationYAP

Identifiers

PMID31262785
PMCPMC6703706
OpenAlexW2953773894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.